Stocktoria
Synergy CHC Corp. SNYR
Synergy CHC Corp. (SNYR) earns a Piotroski F-score of 3/9 (weak financial health). It pays a dividend yielding 37.66% (safety: no dividend). FY2025 revenue was $30.4M at a -40.6% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| SNYR | Synergy CHC Corp. | 3/9 | — | — | -12.8% |
| LEEEF | Leef Brands Inc. | 5/9 | -14.11 | — | +22.1% |
| CHUC | Charlie's Holdings, Inc. | 3/9 | -1.35 | 13.2 | — |
| BON | Bon Natural Life Ltd | 4/9 | 4.25 | — | -21.7% |
| FTLF | FITLIFE BRANDS, INC. | 3/9 | 1.99 | 51.6 | -75.3% |
| PLSH | PANACEA LIFE SCIENCES HOLDINGS, INC. | 4/9 | -13.95 | — | — |
| RAJAF | Cordyceps Sunshine Biotech Holdings Co., Ltd. | 4/9 | -6.82 | — | — |
About Synergy CHC Corp.
Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, Mexico, and internationally. It offers brain health nutritional supplements under the FOCUSfactor brand name; and lifestyle and wellness products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name. The company also provides hand care products under the Hand MD brand name; Neuragen a homeopathic product; and UrgentRx, an over the counter drug. It sells its products through club, mass drug, and other retailers. The company was formerly known as Synergy Strips Corp. and changed its name to Synergy CHC Corp. in August 2015. The company was incorporated in 2010 and is based in Windham, Maine.
FAQ
Is SNYR financially healthy?
Synergy CHC Corp.'s Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak).
Does SNYR pay a dividend, and is it safe?
Yes. Synergy CHC Corp. pays a dividend yielding about 37.66% with a None payout ratio, rated “no dividend” for safety.
How profitable is SNYR?
In FY2025, Synergy CHC Corp. had a net margin of -40.6%.
What is the analyst price target for SNYR?
The average Wall-Street price target for Synergy CHC Corp. is $3.75, about 2700.6% above the recent price, from 1 analysts.
Is SNYR a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Synergy CHC Corp.: a Piotroski F-score of 3/9, a dividend yield of 37.66%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.